Among them, TRβ can inhibit tumor cell migration, invasion and metastasis in both cellular and animal models of HCC and breast cancer by antagonizing the actions of the TGFβ pathway (94, 109), which induces EMT in a p38MAPK-dependent manner in some tumors (110). This evidence concerns the gene THRB and breast carcinoma.